Aarey Drugs & Pharmaceuticals has informed that the Committee of the Board of the Company at its meeting held today has approved the issue price of Rs 54.93 per Equity share (including premium of Rs 44.93 per Equity share) for issuance & allocation of 33,00,000 Equity shares to eligible Qualified Institutional Buyers in the Qualified Institutional Placement, aggregating to Rs 1,812.69 Lakhs; approved and adopted the Placement document dated March 20, 2018, in connection with the Issue, (the ‘Placement Document’); and approved the issue of confirmation of allocation notes to Qualified Institutional Buyers.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Redington | 234.90 |
| Adani Enterprises | 2218.35 |
| Amrapali Industries | 17.53 |
| Rashi Peripheral | 455.25 |
| PDS | 301.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: